Evaluation of Side Effects Associated with COVID-19 Vaccines in Pregnant Women

Background A variety of vaccinations have been developed to fight the coronavirus disease 2019 (Covid-19) 2 years after the coronavirus epidemic spread globally. During clinical studies, these vaccinations were linked to mild to severe side effects. This study aimed to evaluate the short-term side effects of Covid-19 vaccination in pregnant women in Zabol (Iran). Methods This cross-sectional study was conducted between August and October 2021 to collect data on the adverse side effects of Covid-19 vaccinations among 117 pregnant women in Zabol (Iran). A questionnaire was used to collect demographic data, vaccination information, and vaccine complications. SPSS software Version 22 was used to analyze the data at 2 levels descriptive and inferential statistics. Results A total of 117 pregnant women aged 27.67 ± 5.14 years were included. After the first and second doses of Covid-19 vaccinations, 91 (86.7%) and 84 (71.8%) pregnant women, respectively, suffered adverse effects. Moreover, after the first dose, 55(51.4%) and 60 (56.1%) of pregnant women reported fatigue and headache, and after the second dose, 39 (33.3%) and 37 (31.6%) reported fatigue and headache, respectively. Conclusion The side effects reported in our study after receiving Covid-19 vaccinations in pregnant women were similar to those described in clinical studies of vaccines and were mild to moderate, showing that injectable vaccines had safe profiles. More research is needed, however, to assess the long-term side effects of existing vaccines.

[1]  Ishan Garg,et al.  COVID-19 Vaccine in Pregnant and Lactating Women: A Review of Existing Evidence and Practice Guidelines , 2021, Infectious disease reports.

[2]  B. Saeed,et al.  Side effects and perceptions following Sinopharm COVID-19 vaccination , 2021, International Journal of Infectious Diseases.

[3]  Majid Darraj,et al.  Evaluation of Side Effects Associated with COVID-19 Vaccines in Saudi Arabia , 2021, Vaccines.

[4]  Sevgi Özkan,et al.  The effects of the COVID 19 pandemic on vaccine decisions in pregnant women , 2021, Women and Birth.

[5]  David A. Drew,et al.  Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study , 2021, The Lancet Infectious Diseases.

[6]  B. Alghamdi,et al.  Minor to Moderate Side Effects of Pfizer-BioNTech COVID-19 Vaccine Among Saudi Residents: A Retrospective Cross-Sectional Study , 2021, International journal of general medicine.

[7]  H. Kazemi,et al.  The Effects of COVID-19 on Mental Health, Socio-Economic Issues, and Social Interactions in Tehran: A Pilot Study , 2021, The Neuroscience Journal of Shefaye Khatam.

[8]  R. Shenoy,et al.  Survey of symptoms following COVID-19 vaccination in India , 2021 .

[9]  M. Morrone,et al.  COVID-19 vaccines: where we stand and challenges ahead , 2021, Cell Death & Differentiation.

[10]  J. Mascola,et al.  Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine , 2020, The New England journal of medicine.

[11]  Nguyen H. Tran,et al.  Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK , 2020, Lancet.

[12]  K. Chu,et al.  Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial , 2020, The Lancet Infectious Diseases.

[13]  F. Roohvand,et al.  Severe acute respiratory syndrome‐coronavirus‐2 spike (S) protein based vaccine candidates: State of the art and future prospects , 2020, Reviews in medical virology.

[14]  C. Triggle,et al.  A Review of the Progress and Challenges of Developing a Vaccine for COVID-19 , 2020, Frontiers in Immunology.

[15]  Yongli Yang,et al.  Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials. , 2020, JAMA.

[16]  Ping Li,et al.  Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine , 2020 .